Clinical Trial: ATM Variants in Radiotherapy Patients

This study is not yet open for patient recruitment.
Verified by University of Wisconsin September 2005

Sponsored by: University of Wisconsin
Information provided by: University of Wisconsin
ClinicalTrials.gov Identifier: NCT00214227

Purpose

The purpose of this study is to compare the baseline incidence of variant alleles in the ATM and/or other DNA repair genes present in the Native American population versus the non-Native American population. It is thought that a higher baseline incidence of the variant alleles in the ATM gene may correlate to higher rates and higher grades of radiation toxicities noted in the Native American population
Condition
patient who will undergo definitive radiotherapy

MedlinePlus consumer health information 

Study Type: Observational
Study Design: Longitudinal, Defined Population, Prospective Study

Official Title: ATM Variants in Radiotherapy

Further Study Details: 

Expected Total Enrollment:  60

Study start: September 2005

Eligibility

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Male
Criteria

Inclusion Criteria:

  • Indication for radiotherapy. Ability or desire to donate a blood sample and be followed for closely for radiation toxicities

Exclusion Criteria:

-

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00214227

Cancer Connect      800-622-8922 

Wisconsin
      University of Wisconsin Hospital and Clinics, Madison,  Wisconsin,  53792,  United States
Cancer Connect  800-622-8922 

Study chairs or principal investigators

Mark Ritter, MD, PhD,  Principal Investigator,  University of Wisconsin   

More Information

Study ID Numbers:  RO05305
Last Updated:  September 20, 2005
Record first received:  September 13, 2005
ClinicalTrials.gov Identifier:  NCT00214227
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2005-09-27

Resources




Common Treatments

[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Follow Us